Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Drugs in Development
Lead Product(s) : Mocravimod,Inapplicable
Therapeutic Area : Oncology
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Priothera
Deal Size : Undisclosed
Deal Type : Collaboration
EUROAPI and Priothera enter into CDMO collaboration to advance oncology project
Details : The collaboration aims to support Protheria for the development and manufacturing KRP203 (mocravimod), which is being evaluated in the late-stage for the treatment of adult acute myeloid leukemia.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
June 18, 2024
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
ABOUT THIS PAGE
97
PharmaCompass offers a list of Mocravimod API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mocravimod manufacturer or Mocravimod supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mocravimod manufacturer or Mocravimod supplier.
PharmaCompass also assists you with knowing the Mocravimod API Price utilized in the formulation of products. Mocravimod API Price is not always fixed or binding as the Mocravimod Price is obtained through a variety of data sources. The Mocravimod Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Mocravimod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mocravimod, including repackagers and relabelers. The FDA regulates Mocravimod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mocravimod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mocravimod supplier is an individual or a company that provides Mocravimod active pharmaceutical ingredient (API) or Mocravimod finished formulations upon request. The Mocravimod suppliers may include Mocravimod API manufacturers, exporters, distributors and traders.
Mocravimod Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mocravimod GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mocravimod GMP manufacturer or Mocravimod GMP API supplier for your needs.
A Mocravimod CoA (Certificate of Analysis) is a formal document that attests to Mocravimod's compliance with Mocravimod specifications and serves as a tool for batch-level quality control.
Mocravimod CoA mostly includes findings from lab analyses of a specific batch. For each Mocravimod CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mocravimod may be tested according to a variety of international standards, such as European Pharmacopoeia (Mocravimod EP), Mocravimod JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mocravimod USP).
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
